M&A - NovaBay Pharmaceuticals, Inc.

Form Type: 8-K

Filing Date: 2025-01-10

Corporate Action: Acquisition

Type: New

Accession Number: 000143774925000796

Filing Summary: On January 3, 2025, NovaBay Pharmaceuticals, Inc. entered into a Trademark Acquisition Agreement with Phase One Health LLC for the purchase of its wound care product trademarks NeutroPhase, PhaseOne, and OmniPhase for $500,000. This transaction also includes a Transition Services Agreement where NovaBay will provide limited transition services until January 10, 2025, sell existing wound care inventory for $126,000, and provide empty product bottles. Additionally, this transaction is separate from an earlier agreement to sell eyecare products which is pending stockholder approval. The company plans to use the proceeds from these sales for working capital and general corporate purposes. The Trademark Acquisition Agreement includes standard representations and warranties and limits the Company's indemnification liability to 50% of the purchase price for any breaches.

Document Link: View Document